ArticleInternational journal of molecular sciences2023

Generation of a Novel SORT1×HER2 Bispecific Antibody-Drug Conjugate Targeting HER2-Low-Expression Tumor.

Weiliang Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.